Bonifant, Challice L <br/><br/>
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  09 2016 
 - 1615-26 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2016.116  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD20--genetics<br/>CD3 Complex--genetics<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Complement System Proteins--immunology<br/>Cytokines--metabolism<br/>Cytotoxicity, Immunologic<br/>Disease Models, Animal<br/>Genes, Transgenic, Suicide--genetics<br/>Genetic Vectors--genetics<br/>Hematopoietic Stem Cells--immunology<br/>Humans<br/>Immunotherapy--methods<br/>Interleukin-3 Receptor alpha Subunit--genetics<br/>Leukemia, Myeloid, Acute--genetics<br/>Mice<br/>Retroviridae--genetics<br/>Rituximab--pharmacology<br/>T-Lymphocytes--immunology<br/>Transduction, Genetic<br/>Xenograft Model Antitumor Assays